Clinical Trial Update: A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of Abraxane and cisplatin in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED